Precision Medicine in Sepsis
|
|
- Jayson Newton
- 5 years ago
- Views:
Transcription
1 Precision Medicine in Sepsis Jean-Daniel Chiche, MD PhD MICU & Dept Infection, Immunity & Inflammation Hôpital Cochin & Institut Cochin, Paris-F
2
3 Sepsis 2017: a litany of failed clinical trials? l The dark side: RCTs l The bright side Improved ICU outcomes (better general care, less iatrogenic harm) Even positive outcome RCTs from doing less (ventilation, sedation, ) l Starting to understand what may be good for populations l Still strugling to make decisions for the individual
4 Sepsis & Precision Medicine Pharmacogenomics Hemodynamics Immune modulation Steroids Antibiotics
5 The «Omics» revolution
6 The Sepsis / Precision Medicine Agenda 1l Molecular microbiology 2l Personal genomics l 3 Disease characterization l 4 Defining endotypes l 5 The future
7
8 What drives septic phenotypes?
9 Casanova JL et al. Nat Rev Immunol 2004 Waterer GW et al. ARCCM 2011
10 The Sepsis / Precision Medicine Agenda 1l Molecular microbiology 2l Personal genomics l 3 Disease characterization l 4 Defining endotypes l 5 The future
11 Proof of concept
12 Intranasal challenge, 10 6 cfu S. pneumoniae strain D39
13
14 Cause of Death (Parent Dead before 50 y.o.) All causes Biologic Adoptive Infection Biologic Adoptive Vascular Biologic Adoptive Relative risk for adoptee to die from the same cause
15
16
17 TNF2 & Mortality of Septic Shock % Mortality TNF1 TNF Total Septic Shock (SS) SS + Comorbidities n Age SAPS ±16 59±15 59±16 56±14 63±16 53±18 54±21 52±17 52±21 54± ±15 56±19 Comorbidities: cirrhosis, heart failure, cancer & immunosuppressive agents
18 l l l l l l l l Good candidate genes Strong case for the genetic variants typed Appropriate sample phenotyping Sample size Good genotyping Appropriate analysis Appropriate interpretation Replication
19
20 More breakthroughs coming? 7 millions of human genomes sequenced by 2020
21 l From community-acquired pneumonia, peritonitis and meningococcal sepsis to septic shock, organ failure and death l Objective: 2000 patients l Genome-wide analysis
22 The SNP rs in the FER gene is associated with a survival advantage in pts with pneumonia
23
24 The Sepsis / Precision Medicine Agenda 1l Molecular microbiology 2l Personal genomics l 3 Disease characterization l 4 Defining endotypes l 5 The future
25 Find Your Patients on Sepsis Pathways
26
27 l l l Weight loss Anorexia Abdominal mass Fever Tachycardia Hypotension Cancer Sepsis Chemotherapy? Surgery? Radiotherapy? Anti-CD.? Markers Antibiotics? Surgery? Corticosteroids? Adjunctive treatments?
28
29 Improving diagnosis with biomarkers
30 RT-PCR based 21-gene assay developed specifically for patients with ER positive breast cancer
31 Indolent Hormone therapy sensitive No chemo benefit Aggressive Less sensitive to hormone Large chemo benefit
32
33
34
35 Cytomics Chemogenomics Peptidomics Pharmacogenomics Epigenomics Metabolomics hits Omics + Sepsis Omics + Cancer Omics Proteomics Transcriptomics Genomics Bioinformatics
36
37 Whole Genome Transcriptomics - Advancing the science of medicine-
38 Evaluation of gene expression for 100 «class-defining genes». Color & intensity indicate increased / decreased gene expression
39
40 A predictive set of 7 genes enables classification of pts in 2 distinct sepsis response signatures (SRS1/SRS2) 265 pts with CAP, sepsis & organ dysfunction Peripheral blood leucocyte transcriptomics
41
42 New Paradigm for Sepsis Mortality Hotchkiss R et al. Nat Rev Immunol. 2013;13(12):862 74
43
44 l 30 y.o woman victim of terrorist bombing in Brussels in 03/2016 Pelvic & femur fractures Extensive soft-tissue abdominal &pelvic damage Pulmonary contusion Second-degree burns l Early complications Sepsis Femur osteomyelitis Deep wound infections with multi-drug-resistant Enterobacteriaceae
45 Immuno adjuvant therapy Interferon-γ (100 μg x3/week, 5 doses Nivolumab 250 mg D7 D15 D22 D27 D36 D43 D50 Invasive mucormycosis Liposomal ampho-b + posaconazole Gastrectomy + splenectomy Therapeutic success ì lymphocyte, CD8 T-cell counts & monocyte HLA-DR expression î T-cell PD-1 expression
46 The Sepsis / Precision Medicine Agenda 1l Molecular microbiology 2l Personal genomics l 3 Disease characterization l 4 Defining endotypes l 5 The future
47
48 Identified 4 blood gene expression endotypes Mars1 associated with 28d- & 1-yr mortality Combining APS IV & endotypes improves pt risk stratification
49
50
51 The Sepsis / Precision Medicine Agenda 1l Molecular microbiology 2l Personal genomics l 3 Disease characterization l 4 Defining endotypes l 5 The future
52 Molecular Systems Biology (2012) 8: 612
53
54
55
56 A translational research study with n=1
57 ipop: towards the integrative Personal Omics Profile l Combines biological profiles from a single individual over a 14 month period Genomic Transcriptomic Proteomic Metabolomic Autoantibodies l Monitor omics to study molecular complexity & dynamic changes in physiologic & disease states
58
59
60
61 v Can a genome sequence be used to estimate disease risk in a healthy individual? v Can the disease be detected by monitoring traits and markers associated with that disease?
62
63 l Many unaddressed challenges Interpreting regulatory/non protein coding regions DNA Methylation Microbiome Exposome
64 /
65 I think the biggest innovations of the 21 st century will be at the intersection of biology and technology. A new era is beginning